# Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer

> **NCT01461759** · PHASE2 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 59 (estimated)

## Conditions studied

- Advanced or Recurrent Endometrial Cancer

## Interventions

- **DRUG:** Doctaxel
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01461759
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2017-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01461759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01461759, "Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01461759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*